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Abstract 
 
Purpose 
In recent years, the assessment of health-related quality of life (HRQoL) has been recognized 
as particularly informative to health care providers.  For adolescents and young adults 
(AYAs), the impact of a cancer diagnosis and subsequent treatment is likely to be distinct 
from other age groups given the unique and complex physical and psychosocial challenges of 
this developmental phase.  The objective of this study was to capture the HRQoL issues 
described by AYAs with cancer using thematic analysis. 
Methods 
Semi-structured interviews were carried out with 45 AYAs aged 14-25 years from 6 
countries.   
Results 
The most prevalent cancers presented were leukemia (n=12) and lymphoma (n=8).  AYAs’ 
descriptive accounts were analysed and 12 categories identified:  Symptoms (i.e., pain, 
nausea, vomiting) (84% AYAs); activity limitations (education, leisure time activities) 
(87%); disrupted life plans (29%); social (loss of friends, family life) (91%); emotional 
(depression, anxiety) (64%); body image (conscious of changed appearance) (36%); self-
appraisals (greater maturity, braver) (47%); outlook on life (altered priorities, increased 
motivation to achieve) (33%); lifestyle (restricted diet, avoidance of infections) (18%), 
treatment-related (absence of age-appropriate information, treatment burden) (31%); fertility 
(24%); and financial concerns (13%).   
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Conclusions 
A wide spectrum of both negative and positive issues were described.  Several of these 
issues, such as disrupted life plans and difficulty establishing romantic relationships, are 
likely to be more common to AYAs with cancer and might not be captured by existing 
HRQoL measures.  Recognition of these issues and finding ways of addressing them should 
be seen as an essential component of AYA-tailored cancer care. 
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Introduction 
Health-related quality of life (HRQoL) is increasingly recognized as integral to health 
outcome assessment with an increased emphasis on the development and use of patient 
reported outcome measures (PROMs).1  According to the World Health Organization (WHO) 
Quality of Life Group (QLG), HRQoL can be defined as a multi-dimensional construct 
shaped by physical health, psychological state, level of independence, social relationships, 
personal beliefs and their relationship to important environmental features.2  HRQoL 
assessment can improve routine clinical practice by providing patients with a platform to 
express concerns which might otherwise remain undetected.3  For Adolescents and Young 
Adults (AYAs) with cancer, the assessment of HRQoL concerns is particularly pertinent 
given the complex developmental challenges they face.4-6   
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Irrespective of a diagnosis of cancer, AYAs find themselves in a period of transition from 
childhood to adulthood characterized by significant physical and cognitive changes and is 
heavily laden with critical psychosocial challenges.  There is variability in the age definition 
of AYAs;7 and can be as broad as ranging from 15-39 years8 although in the the UK, the age 
range is more conservative with AYA oncology services tailored for 15-25 year olds.9 
According to Erikson’s psychosocial stages of development10, adolescence is a time when 
individuals start to develop their own identity and vision of the future and seek the adoption 
of roles in an attempt to become an adult and fit into society.  This phase is characterized by 
decisions regarding career choices, and challenges relating to peer relationships, as well as 
establishing autonomy from family members.  The development of intimate relationships and 
questions relating to sexuality are also integral features during adolescence and early 
adulthood.  A diagnosis of cancer during this crucial developmental stage might further 
complicate the negotiation of these challenges,4 for example,  young people with cancer 
might find themselves having to relinquish their newly found independence as they rely on 
others to care for them. 4  Relationships with peers  and romantic partners might also be 
negatively impacted by cancer. 4  Adolescents with cancer interviewed by Stinson et al. 11 
described feeling less attractive and desirable to others which in turn impacted on their self-
esteem and confidence in engaging in romantic relationships.   In addition, young people 
might not be as well-equipped as their older counterparts in coping with the demands of a 
cancer diagnosis.4 Furthermore, for AYAs, the development and realisation of future plans 
might also have to be put on hold due to cancer.  In Chiang et al.’s qualitative study, 12 future 
life plans were described by adolescents as interrupted due to a lack of participation in 
activities, which in turn impaired their self-performance and compromised the realisation of 
talents.  It therefore follows that compared with other groups, AYAs are likely to experience 
more distress and poorer HRQoL following a diagnosis of cancer.4; 13   
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A number of PROMs have been used to evaluate HRQoL in AYAs with cancer, many of 
which represent adaptations from pediatric or adult versions of measures.14 Issues assessed 
include physical, cognitive, restricted activities, relationships with others, fertility, emotions, 
body image and spirituality / outlook on life.  Choice of measurement tool is often driven by 
the purpose of the study.  The types of HRQoL issues captured from these studies thus reflect 
the purpose of the study and measure used. Open-ended, interview based studies, however, 
provide the opportunity for general, less directed, discussions relating to the impact of cancer 
and its treatment on HRQoL.   
As part of our study looking at the feasibility of developing a new European Organization for 
Research and Treatment of Cancer (EORTC) HRQoL measure specific to AYAs receiving 
treatment or supportive care for cancer, we carried out a  literature review of 69 studies 
involving AYAs diagnosed and undergoing treatment for cancer. 14 We did not identify any 
open-ended, interview-based study asking both adolescents and young adults to describe all 
the ways in which their life has been affected by cancer and its treatment.  Some of the 
interviews involving adolescents or young adults focused solely on  a particular domain of 
interest such as pain,15 fatigue,12;16 body image,17 romantic relationships and fertility.11  The 
other, less structured, interviews included adolescents as part of a sample including 
children18-20 or focused only on adolescents21 or young adults.22   
The objective of the current study is to extend previous research by investigating all aspects 
of HRQoL as described by both adolescents and young adults receiving treatment or 
palliative care for cancer.  The focus is on the diagnosis and treatment period rather than the 
post-treatment or survivorship phase, which presents its own set of challenges.23 For the 
purposes of the current study, and in line with the age range for AYA oncology service 
provision in the UK, we define AYAs as aged between 14 and 25 years.     
7 
 
Methods 
The study protocol was peer reviewed and approved by the EORTC QLG.  The format for the 
study was informed by the EORTC QLG module development guidelines.24 
Participants 
AYAs aged between 14 and 25 years receiving treatment or supportive palliative care for 
cancer from 7 research centres across France, Israel, Norway, Poland, the Netherlands and 
UK were invited to take part in the study.  Participants were recruited and interviewed during 
their clinic visit or hospital stay by the delegated researcher for each site.  Those who had 
completed treatment and attending a clinic for follow-up only were excluded from the study.    
Procedure 
Ethical and research governance approvals were obtained at each centre in accordance with 
local requirements.  Participants and, where appropriate, parents (of participants aged 14 and 
15 years), were given verbal and written information about the study.  Interviews were 
arranged once consent and, where appropriate, assent were given. 
Interviews 
Interviewers received detailed instructions from the study coordinator (SS) regarding the 
format of interviews and checks were made to ensure consistency across research sites.  All 
interviewers had previous experience of interviewing (either in a qualitative research or 
clinical capacity) and were well acquainted with the EORTC module development 
framework24 as they had been involved in previous EORTC QLG studies. Before the 
interview started, a case report form was completed together with participants and included 
details relating to education attainment, employment status and domestic situation.  
Participants were also asked to self-report any comorbidities and to complete a measure of 
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performance status,25 which gave a broad indication of the impact of disease and treatment on 
daily activities.   
The interviews followed a semi-structured format opening with a general question asking 
participants to describe the different ways in which their life has been affected by cancer and 
its treatment.  Participants were then asked several prompt questions informed by our 
literature review14 relating to certain aspects of life that might have been affected by cancer.  
In addition, the EORTC core questionnaire (EORTC QLQ-C30)26 was shown to participants 
to encourage further discussion. The interview template is available as supplementary 
material.  Following completion of the interview, the researcher accessed medical notes to 
record information relating to diagnosis and treatment schedules. 
Interviews were audio-recorded and summaries of the content of the interviews were 
prepared in the form of narratives with quotes and translated where appropriate by each 
interviewer and sent to the study co-ordinator (SS) for analysis.  The content of the interviews 
was analysed using the principles of thematic analysis.27 A list of preliminary codes or 
themes was developed inductively by SS with iterations to the master code list carried out by 
members of the research team (ASD, OH, GR, BV).  Each interviewer was also asked to 
check the application of themes for the interviews they had conducted and any conflicts in 
interpretation resolved following discussions with the research team. Coding assumptions 
were continually reviewed and an audit trail of all research team discussions recorded to 
enhance rigour.   
Examples of each theme were extracted from the interviews as direct quotes or summaries of 
issues raised.  Each participant was given a code with their country identifier followed by a 
number.  The following codes were given to each country:  France: FR, Israel: IS, 
Netherlands:  NL, Norway: NO, Poland: PO, United Kingdom: UK. 
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Results 
Participants 
Collaborators were asked to recruit, where possible, participants with a spread of ages, 
diagnosis type and treatment/palliative status.  Recruitment continued until no new issues 
were raised with accumulating data reviewed after every fifth interview and recruitment 
ended after 45 interviews. All participants opted to be interviewed alone.  Full details 
regarding the demographics and clinical characteristics of the sample are presented in Table 
1.  The sample included an almost even split of males (53%) and females (47%), mean age 
20.3 years, 27% had completed compulsory education, i.e. the minimum period of education 
imposed by law, 20% were either currently enrolled in or not able to complete compulsory 
education, and 38% had enrolled in or completed college.  Only 22% of the sample were 
currently in full time or part time employment.  The majority of the sample lived with a 
partner (64%) or parents (24%).  Participants presented with 12 different cancer types with 
leukemia (28%) and lymphoma (18%) the most predominant diagnoses.  The median time 
since diagnosis was 9 months and ranged between 1 month and 7 years.  The majority of 
participants were currently on treatment with curative intent (78%), predominantly 
chemotherapy (53%).  Twenty participants had undergone surgery and one was awaiting 
surgery.  The majority (80%) of the sample did not report any co-morbidities. Thirty three 
percent described themselves on the ECOG performance scale as fully active and 42% as  
restricted in physically strenuous activity.   
Insert Table 1 about here 
Themes 
HRQoL issues were extracted from the interviews and organized within the following 12 
thematic categories: symptoms, activity limitations, disrupted life plans, social, emotional, 
body image, self-appraisal, outlook on life, lifestyle, treatment-related concerns, fertility and 
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financial concerns. Table 2 presents these categories along with example quotes from 
participants.    
Insert Table 2 about here 
Symptoms 
The majority of participants (n=38, 84%) talked about symptom side effects of their cancer 
and its treatment including pain, nausea, vomiting, fatigue, sleep-related problems, loss of 
strength and energy, shortness of breath, cognitive issues, difficulty gaining weight and 
mobility problems.  Over half the participants (n=25, 56%) talked about problems relating to 
fatigue or loss of energy, for example, not being able to resume their education, return to 
work or go out with friends.  Participants talked about a generalized state of feeling unwell 
and not feeling “normal”, for one 20 year old with acute lymphoblastic leukemia (UK003), 
feelings of nausea and headaches contributed to not feeling his “usual self”.  Some symptoms 
such as weight changes and hair loss resulted in visible bodily changes and served as constant 
reminders of the cancer: 
“..the hair loss was the most disturbing as it made the cancer visible, a constant reminder” 
(NL007, 22 years old with lymphoma)   
Activity limitations 
Most AYAs (n=39, 87%) reported that their cancer and its treatment restricted their activities.  
Twenty (44%) participants discussed the impact on leisure activities and hobbies and in 
particular restricted participation in sporting activities due to lack of strength and tiredness. 
AYAs also found themselves restricted in being able to go out and pursue activities due to 
risk of infections and 3 (7%) participants described having to postpone their travel plans. 
The impact of activity limitations on mood was also described; one 17 year old participant 
with leukemia (PO009) reported feelings of frustration from not having the energy to carry 
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out even the most simplest of tasks.   A 14 year old with leukemia described the impact of not 
being able to play soccer: 
“Not to be able to play soccer and not to be able to do nearly anything, have to think about 
the illness all the time; I find it boring” (NO001). 
Fourteen (31%) AYAs talked about the impact of being ill on work life, for example in terms 
of having to take sick leave, reducing the number of hours worked or having to change jobs:   
"I had a very promising job, but now I have to stay on sick leave" (PO011, 23 years old 
diagnosed with breast cancer). 
AYAs also talked about worries relating to returning to work and future employment 
prospects. 
Twenty eight (62%) participants talked about interruptions to their studies and, for 7 (16%), 
disrupted education and physical limitations impacted on their chosen career pathway.   
Disrupted life plans 
Life plans being put on hold was a recurring theme, the emotional impact of which was 
exacerbated by comparisons made with achievements realized by their peers.  An 18 year old 
male with acute lymphoblastic leukemia explained:    
“I feel like I’m not going anywhere, It’s like my life has been put on pause….I see everyone 
else getting on with their lives” (UK002).   
A 19 year old with gynecological cancer (IS005) recounted that one moment she was on the 
same path as the rest of her friends and a moment later she had to face a completely different 
reality involving hospital admissions and tests.  Disrupted life plans were also regarded as 
causing developmental delays as AYAs find themselves in a different developmental phase to 
their peers.  
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In addition, a 19 year old a male with leukemia (IS003) talked about difficulties in making 
plans for the future due to the time “wasted” in hospital.  
Social 
The social impact of cancer and its treatment was described by 41 (91%) AYAs and included 
the effects on friendships, family and romantic relationships.  An inability to go out and 
socialize with peers was frequently reported and for some led to feelings of isolation.  Several 
AYAs sensed that their peers found it difficult to relate to what they were going through and 
this caused difficulties in communicating with them: 
“My friends do not understand my situation, it’s difficult for me to explain to them” (NE004, 
19 years old with lymphoma) 
Friends were described as being in shock that someone of their age could become so 
seriously ill and potentially die and they could not cope with this thought: 
“They consider you dead before you die….“it’s like they put their fingers in their ears and 
walked away”. (UK005, 21 years old with non Hodgkin lymphoma) 
Participants described losing friendships and feeling let down by others as friends were often 
scared to contact them.  One participant aged 23 years with a brain tumour explained that her 
friends had adapted to her limitations but she felt bad about it (UK009).  Other participants 
also shared the concern of being a burden to others especially to family members.  Having to 
rely on others for help, for example, for self-care was noted as something people of their age 
do not normally have to do:   
“It’s like you’re a kid again” (UK005, 21 years old with non Hodgkin lymphoma) 
Participants described difficulties associated with surrendering the independence enjoyed by 
their peers especially as they often found themselves having to move back in with parents and 
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for a 23 year old participant (UK009) this meant moving back into her parent’s house with 
her husband at a time when they should have been developing their relationship.   While 
many AYAs talked about having to ask family to help look after them, some also had young 
families of their own: a 23 year old with gynecological cancer (IS004) had to call upon help 
from the family to care for her baby.  AYAs talked about the impact their diagnosis had on 
their family and home life both emotionally and practically.  Several AYAs were concerned 
about the worry and stress brought upon their parents as well as the impact on siblings both 
emotionally and practically in terms of them receiving less attention from parents: 
“I feel bad for the time my parents spend taking care of me…my father missed work and 
mum is with me at hospital instead of taking care of my little brothers” (IS003, 19 year old 
male with leukemia).  
Several AYAs reported that their parents had put their own careers and employment on hold 
in order to care for them: 
“My mum had to change her career path to care for me” (UK003, 20 year old male with acute 
lymphoblastic leukemia). 
For some participants, cancer and its treatment had put the relationship with their partners 
under strain, for example, a 20 year old male with testicular cancer (PO006) talked about 
marital difficulties resulting from an inability to communicate feelings to his spouse.  Limited 
opportunities for spending time with partners and for intimacy were also described.  A 23 
year old diagnosed with breast cancer (PO003) explained that her sex life and plans to start a 
family had to be put on hold.  An 18 year old male with acute lymphoblastic leukemia 
(UK002) also expressed concern over not being able to have a “usual” relationship and share 
a bed with his girlfriend.  Two of the AYAs went through a relationship break up since their 
diagnosis. 
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Difficulties in establishing new romantic relationships due to limited opportunities, body 
image and self-esteem issues were also described.  A 19 year old with leukemia (IS003) 
expressed concerns over how girls would view him and lacked confidence in dating: 
“I used to date a lot before I got sick” (IS003) 
For a 22 year old male with testicular cancer (PO005), concerns rested with future “private” 
relationships due to uncertainty over fertility.   
Not all accounts of the social impact of cancer were negative as 4 (9%) AYAs described 
opportunities to make new friends with fellow patients and 16 (36%) felt that their 
relationships with family and friends had been strengthened as a result of more time devoted 
to these relationships. 
Emotional 
AYAs described the emotional impact of cancer including feelings of sadness and depression 
often brought about by restrictions to previously enjoyed activities and disrupted life plans. 
Seventeen (38%) AYAs worried about their diagnosis and the implications for their future..  
Two (4%) AYAs described feeling scared about their diagnosis and one talked about feeling 
afraid of dying: 
“I became paralysed by my diagnosis” (PO011, 23 years old with breast cancer) 
Several AYAs expressed feelings of disbelief and shock at their diagnosis.  Feelings of anger 
were also described; a 23 year old with gynecological cancer (PO007) was angry with herself 
for not attending regular screening while a 20 year old male with testicular cancer (PO006)  
was angry at the surgery he had to have (removal of testicle) which also left him feeling 
embarrassed.  Two (4%) participants felt that they had been let down by their body.  A 23 
year old participant with gynecological cancer (PO012) described concerns about the long 
term effects of the disease and life not being able to return to normal: 
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"I am afraid that once the treatment ends I will not know how to go back to everyday life"  
This participant (PO012) also described being consumed by thoughts about the disease while 
a 21 year old male with a neuroendocrine tumour (NL002) was worried that any physical 
ailment meant that his disease was progressing.   
Four (9%) AYAs described feelings of boredom from the time spent in hospital and 
restrictions imposed on them, which was in contrast to their more active pre-diagnosis 
lifestyle: 
 “time is not spent in a valuable way, time you will never get back again” (UK005, 21 years 
old, non Hodgkin lymphoma) 
Body image 
Symptoms presented above such as hair loss, changes to weight and rashes resulted in 
appearance changes which impacted on self-esteem and had social repercussions as they 
often felt self-conscious in front of others and even too embarrassed to leave the house: 
“I didn’t recognize myself in the mirror” (UK005, 21 years old with non Hodgkin lymphoma)   
Participants also referred to the lack of preparation for such significant changes in 
appearance.  Altered appearance also affected feelings of femininity and manliness with 
accounts of feeling disfigured.  Concerns relating to permanent changes due to scars were 
also voiced and a 23 year old with gynecological cancer (PO007) worried that she would not 
be attractive following her treatment.  By contrast, a 21 year old with bone cancer (NL008) 
described no longer being worried about his appearance and what others thought. 
Self-appraisal 
AYAs not only described changes to their physical appearance but also to the way they felt 
about themselves: 
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 “I can’t be the person I was last year”.  “It changes you and you can’t do anything about it” 
(UK002, 18 years old with acute lymphoblastic leukemia).    
AYAs described greater self-awareness and as mentioned earlier within the context of body 
image and relationships with others, several AYAs described feeling less confident in 
themselves and their bodies.  A 23 year old with breast cancer (PO003) explained how her 
diagnosis had shattered her perception of herself.  There were also accounts of being less 
tolerant to others who appear to have less to deal with: 
“I find it hard to be understanding of others who do not cope well with diseases” (NL010, 22 
years old with thyroid cancer) 
In contrast, 4 (9%) AYAs talked about feeling more confident and self-assured through their 
experiences. There were also accounts of feeling braver, stronger, more mature, and positive. 
“…..it impacts you as a person, I am now more sympathetic, more sensitive to others and 
more motivated to help others” (UK001, 17 years old with acute lymphoblastic leukemia) 
“I have become more grown up in a way” (NO003, 19 years old with Ewing’s sarcoma) 
Changed outlook on life 
Ten (22%) AYAs talked about cancer changing their outlook on life, for some this was a 
more positive outlook on life and the future with different priorities and a desire to live life to 
its fullest and embrace every opportunity offered.  A 21 year old male with non Hodgkin 
lymphoma described a “greater thirst for life” with life taking on an intensity (UK005) as 
well as a greater motivation to achieve personal goals and succeed academically:   
“…it gives you a pathway, and motivation to do things”  
A 22 year old participant with non Hodgkin lymphoma (NL012) explained that cancer had 
provided him with greater life experience and an awareness of different emotions.  The 
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experience of cancer also brought some AYAs face to face with their own mortality, which 
also led the realization of the fragility of life and to feelings of gratitude for being alive and 
not taking things for granted.  
Lifestyle 
Eight (18%) participants found themselves having to make lifestyle changes in terms of 
following special diets and minimising risk of infection particularly during treatment.  While 
several participants described feeling motivated to follow a health promoting lifestyle, some 
described the struggles associated with the restricted food and drink intake, and the avoidance 
of high-risk situations, which impacted on their ability to go out and enjoy the things their 
peers take for granted: 
“I am not able to meet friends or be part of any social activity due to risk of infection” 
(IS005, 19 years old with gynecological cancer) 
 
Treatment-related 
AYAs discussed the burden imposed by their treatment and in particular the length of 
treatment. Dissatisfaction with care was also a common theme and included not being taken 
seriously because of their age and misdiagnosis when they first presented with symptoms: 
“…they made multiple mistakes and did not take me seriously" (NL007, 22 years old with 
lymphoma) 
 AYAs also talked about lack of age appropriate care, information on how to lead a healthier 
lifestyle, what to expect from treatment, in terms of age-specific effects, and adequate 
psychosocial support.  A 25 year old with testicular cancer (NL014) described the frustration 
felt as the hospital staff expressed little understanding of the strains imposed by treatment on 
his young family.  The lack of a young adult ward was also discussed with one 19 year old 
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with melanoma (NL006) describing feelings of loneliness from being the youngest patient on 
the ward. 
 
Fertility 
Both male and female participants considered the impact of treatment on their ability to have 
children: 
"What will happen if I will not be able to be a mother?" (PO011, 23 years old with breast 
cancer). 
Some females talked about the impact of becoming pregnant in terms of cancer recurrence 
and having to alter medication.  For a 25 year old male with testicular cancer (NL014), 
reduced fertility and the desire for a bigger family caused tension and uncertainty for him and 
his partner.  Three (7%) AYAs talked about looking into fertility preservation methods. 
Financial impact  
Six (13%) of the AYAs interviewed discussed the financial impact of their illness.  Although 
some AYAs received some financial help, financial struggles were discussed within the 
context of not being able to work and, in some cases, having a young family to support.  
Financial constraints also forced plans, such as purchasing a house, to be put on hold.  In 
addition, a 19 year old patient with sarcoma (UK010) talked about the significant costs of 
sperm banking.  
  
Discussion 
From our interviews with both adolescents and young adults with cancer, we generated a list 
of inter-related HRQoL themes reflecting the multi-dimensional nature of HRQoL.2 .  This 
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study represents an extension of previous qualitative studies in the literature by employing 
semi-structured interviews with a larger cohort of AYA patients with different cancer 
diagnoses representing numerous cultural backgrounds. We have expanded on previous 
research by providing a detailed overview of a wide range of HRQoL issues in a more 
culturally diverse sample thus our findings could be argued to be more comprehensive and 
have greater applicability .   
Although our interviews followed a script, the emphasis was on giving AYAs the opportunity 
to tell their own unique story and this is reflected in the number and diversity of HRQoL 
themes (both positive and negative) captured in this study.  Issues were organized according 
to the following 12 broad themes: symptoms, activity limitations, disrupted life plans, social, 
emotional, body image, self-appraisal, outlook on life, lifestyle, treatment burden, fertility 
and financial. While it could be argued that these issues are familiar concerns for other age 
groups, they are likely to be more pronounced in AYAs4.   The impact of symptoms on 
AYAs’ ability to engage in everyday activities, partake in sports, attend school, work and 
interact with others was frequently reported in the interviews and is consistent with previous 
research with young people with cancer.15;18;21;22  In line with Hinds et al. (2004),20 we found 
that AYAs often use their peers’ position in life as a frame of reference leading them to 
conclude that they are falling behind where they should be in life.  Most AYAs in our study 
(91%) described the impact of cancer on friendships, family or romantic relationships 
although not all accounts were negative, for example, strengthening of existing relationships 
and opportunities to forge new bonds with fellow AYAs with cancer were also described. 
Our interviews also covered the issue of fertility which is idenified as a significant 
psychosocial concern amongst both male and female AYAs with cancer28 with increasing 
recognition of the need to allow space in conversations with AYAs to discuss the often 
uncomfortable topic of fertility as well as sexual concerns.29 
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AYAs in our study described a range of feelings surrounding their diagnosis with cancer and 
the effects of its treatment including initial feelings of shock and disbelief, frustration and 
anger at not being able to follow the pathway of their peers, as well as concerns over the 
future and mortality.   
Body image concerns described by AYAs in our sample have also previously been identified 
as an important aspect of the AYA’s experience of cancer 17; 21 impacting on self-confidence 
and self-esteem. 14; 17; 21 Negative self perceptions did not however feature in the stories of all 
AYAs we interviewed.  AYAs also talked about improved self-appraisals, such as greater 
maturity and these replicate findings in the literature.18; 21 In addition, for some AYAs we 
interviewed, this positivity extended to changes in life perspective and subsequent priority 
reorganization which has previously been described in the literature within the context of 
personal growth 18; 22 as well as response shift in HRQoL evaluation.30 
Financial concerns resulting from the direct and indirect costs of cancer were also raised in 
the interviews and while they may not be unique to AYAs, they are likely to be more 
prominent during adolescence and adulthood, a time when AYAs might have only just 
recently secured employment and therefore might not enjoy the benefits, such as sick pay, 
accrued by their older counterparts.  In addition, AYAs might have limited savings and 
possibly student debts,31 a young family to support or significant financial commitments in 
the form of mortgage repayments.  For an AYA with cancer, it follows that identifying and 
accessing means of financial support can be a potentially daunting task. 
This study provides a detailed insight into the widespread impact of cancer and its treatment 
on the lives of AYAs by collating all the different HRQoL issues as described by AYAs.  
Activity limitations, social impact and symptoms were highlighted as the most commonly 
discussed issues in our sample. However, it could be argued that these issues were more 
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commonly raised in response to prompts relating to these topics and exposure to the EORTC 
QLQ-C30 items which measure these issues.  Thus, we are not in a position to make claims 
regarding prevalence and generalize from our sample.  In addition, this study did not make 
formal age comparisons in HRQoL issues therefore we are only able to speculate that issues 
such as the opportunity for establishing intimate relationships and disrupted career plans 
might be more familiar to AYAs compared with older adults.  We acknowledge that several 
of the HRQoL issues captured by this study, for example, symptoms and emotions, do not 
begin and end in the AYA years.  In addition, it could be argued that we should not treat 
AYAs with cancer as a homogeneous entity32 and that a 14 year old will not share the same 
concerns as a 25 year old.  Again, identifying differences within our sample according to age 
was beyond the scope of our current study.  Although our focus was on AYAs receiving 
treatment or palliative care, the issues raised are likely to be familiar to AYAs living beyond 
cancer treatment.33 
In this paper, we have provided a comprehensive list of HRQoL issues described by AYAs 
undergoing treatment for cancer.  It is likely that not all of these issues are covered by any 
one of the existing PROMs used with AYAs,14 a finding which is consistent with the work of 
Anthony et al. (2017)34 in the context of pediatric oncology.  The findings from this study 
form part of a larger EORTC QLG study and will inform the development of a new AYA-
specific measure that will include all relevant and important issues for AYAs undergoing 
treatment or receiving palliative care for cancer. Our study also highlights the diverse and 
potentially unique needs of AYAs with cancer.  The use of an AYA-specific HRQoL module 
could facilitate discussion of such needs that might otherwise be overlooked.  In addition, 
information gathered from HRQoL assessments can be used to tailor treatments and has the 
potential to support the effective delivery of care and improve clinical outcomes as well as 
HRQoL beyond cancer.3,35  
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Table 1.  Demographic and clinical background of the sample  
Variable Total 
Interviewed 
(N=45) 
N (%) 
Patients recruited per country  
(country Identifier) 
 
Netherlands (NL) 13 (28.9%) 
Poland (PO) 12 (26.7%) 
United Kingdom (UK) 10 (22.2%) 
Israel (IS) 6 (13.3%) 
Norway (NO) 3 (6.7%) 
France (FR) 1 (2.2%) 
Gender  
Male 24 (53.3%) 
Female 21 (46.7%) 
Age (years)  
Mean (standard deviation) 20.3 (2.8) 
Range 14-25 
Education level  
Currently not able to complete education 5 (11.1%) 
Currently in compulsory education 4 (8.9%) 
Compulsory school education completed 12 (26.7%) 
Post compulsory school education 
(college) 
17 (37.8%) 
University 7 (15.5%) 
Employment status1  
Full time 5 (11.1%) 
Part time 5 (11.1%) 
Sick leave 11 (24.4%) 
None 16 (35.6%) 
Other 8 (17.8%) 
Living situation2  
Alone 2 (4.4%) 
Partner 29 (64.4%) 
Parents 11 (24.4%) 
Living with others 4 (8.9%) 
Time since diagnosis (months)  
Median 9 
Range 1-87 
Disease status  
Localized  16 (35.6%) 
Metastatic 9 (20.0%) 
Not applicable (Leukemia, lymphoma) 20 (44.4%) 
Diagnosis  
Leukemia 12 (26.7%) 
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Lymphoma 8 (17.8%) 
Gynecological 5 (11.1%) 
Testicular 4 (8.9%) 
  
Bone 3 (6.7%) 
Sarcoma 3 (6.7%) 
Head and neck 3 (6.7%) 
Brain and central nervous system 2 (4.4%) 
Breast  2 (4.4%) 
Thyroid 1 (2.2%) 
Melanoma 1 (2.2%) 
Neuroendocrine 1 (2.2%) 
Treatment status   
Currently on treatment 35 (77.8%) 
Supportive / palliative care 10 (22.2%) 
Treatment type3  
Chemotherapy 24 (53.3%) 
Radiotherapy 8 (17.8%) 
Hormonal 4 (8.9%) 
Targeted therapy 3 (6.7%) 
Stem cell transplantation 1 (2.2%) 
Psychological 1 (2.2%) 
Co-morbidities4  
None 36 (80.0%) 
Renal  3 (6.7%) 
Respiratory  2 (4.4%) 
Muscular  2 (4.4%) 
Hypertension 1 (2.2%) 
Neurofibromatosis type 1 1 (2.2%) 
ECOG Performance Status5  
0 (Fully active) 15 (33.3%) 
1 (Restricted in physical strenuous 
activity) 
19 (42.2%) 
2 (Unable to carry out work activities) 9 (20.0%) 
 
12 participants within the none category and 2 within the other were students 
2 1 participant lived with a partner and parents 
3 Several participants were receiving multiple treatments.  Details on treatment type were 
unavailable for one participant 
4 Several participants indicated more than one co-morbidity. Co-morbidity details were not 
collected for one patient.  One patient had been diagnosed with attention deficit hyperactivity 
disorder. 
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5 One participant indicated a score of 1.5 (between restricted in physical activity and unable 
to carry out work activities).  Performance status was not indicated for one participant. 
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Table 2.  HRQoL Themes 
HRQoL Issue Extracts from interviews Number (percentage) of 
participants referring to 
the issue  
Symptoms  38 (84%) 
Pain “…difficulties controlling pain 
restrict daily routines” (PO008)  
5 (11%) 
Nausea & Vomiting “Feelings of nausea and 
headaches make me not feel 
normal” (UK003) 
11, 7 (24, 16%) 
Lack of appetite “I have lost my appetite which 
is a cause for concern for 
doctors” (PO009) 
 
3 (7%) 
Weight gain “I see myself as fatter” 
(UK002) 
1 (2 %) 
Weight loss or difficulty 
gaining weight 
“I have lost weight which is a 
positive thing (not for the 
doctors)” (PO009) 
3 (7%) 
Tiredness or lack of energy  “I am not able to do anything 
useful because of my tiredness” 
(PO009) 
25 (56%) 
Weakness or loss of 
strength 
“I am physically weaker and 
cannot do things around the 
house” (PO006) 
12 (27%) 
Heartburn “heartburn…problems that in 
the past I considered to be adult 
problems” (IS003) 
1 (2%) 
Bowel (constipation, 
diarrhoea) 
“Constipation imposed the 
biggest restriction” (UK009) 
4 (9%) 
Hair loss  “…I consider the hair loss the 
most disturbing…it makes the 
cancer visible…a constant 
7 (16%) 
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reminder…made me feel 
unfeminine” (NL007) 
Shortness of breath “…because of my shortness of 
breath, I cannot do things that 
are normal” (UK002) 
4 (9%) 
Trouble sleeping …work performance is affected 
due to trouble sleeping” 
(PO002) 
10 (22%) 
Mobility problems “My mum has to take me 
everywhere….I am afraid that I 
won’t be able to walk normally 
after treatment” (PO001) 
5 (11%) 
Difficulty concentrating “I find it difficult to concentrate 
especially when I am pre-
occupied with concerns about 
the future” (PO004) 
10 (22%) 
Activity limitations  39 (87%) 
Impact on hobbies or 
leisure time activities 
 “I used to do a lot of things, I 
played soccer four times a 
week….”I particularly miss 
soccer” (NO001) 
20 (44%) 
Not able to bathe, take 
showers or dress yourself 
“I feel angry about not being 
able to wash myself and shower 
with the line in” (UK002) 
3 (7%) 
Not able to go out  “I do not go out much due to 
lack of energy” (NL011)  
6 (13%) 
Restricted daily activities  “I am not able to do everything 
even though I think I can do it” 
(NO002) 
4 (9%) 
Interrupted education “I am worried about wasting 
time….instead of promoting 
myself towards education and 
28 (62%) 
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future planning, I have to stay 
in hospital” (IS003) 
Employment  “I had a very promising job, 
but now I have to stay on sick 
leave” (PO011) 
14 (31%) 
Disrupted life and career 
plans 
 13 (29%) 
  “Currently I feel like 
everything I did sort of 
stopped” (PO009) 
 
 
Social  41 (91%) 
Loss of friends  “…it’s like they put their 
fingers in their ears and walked 
away” (UK005) 
7 (16%) 
Isolation from friends “I could not be with friends” 
(NO003) 
8 (18%) 
Less time to go out with 
friends 
“I have less time to meet up 
with friends” (IS004) 
2 (4%) 
Greater dependence on 
others 
 
“I have had to rely on help from 
others, for example with 
medication….things teenagers 
ordinarily wouldn’t have to 
worry about” (UK011) 
15 (33%) 
Greater burden on others “I feel useless and a burden to 
others because I am limited in 
being able to help around the 
home” (PO006) 
2 (4%) 
Change in living situation  “We had to move back in with 
my parents at a time we should 
have been developing our own 
relationship” (UK009) 
4 (9%) 
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Impact on family members  “…it was probably mum and 
dad who were most anxious” 
(NO003) 
 
14 (31%) 
Impact on family life “…our life together as a young 
family is put on hold” (IS004) 
 “My dad has had to miss work 
and my mum should be looking 
after my brothers instead of 
me” (IS005) 
 
6 (13%) 
Unable to care for others “…I cannot take care of him 
and that is what I find difficult 
to deal with” (IS004) 
1 (2%) 
Impact on romantic / sexual 
relationships 
 “I used to date a lot before I 
got sick and now I lack 
confidence in talking to other 
women” (IS003) 
 
14 (31%) 
Strengthening existing 
relationships 
“I became closer to my family 
and “real” friends” (NL001) 
 
16 (36%) 
Opportunity to make new 
friends 
 “I made new friends at the 
hospital…we helped each other 
feel positive about the future” 
(PO001) 
 
4 (9%) 
Appreciation of the support 
received from others 
“I have supportive friends who 
try to raise my spirits” (PO004) 
7 (16%) 
Less tolerant of others  
“I am less tolerant and get more 
annoyed with others” (PO006) 
2 (4%) 
Emotional  29 (64%) 
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Feelings of sadness or 
depression 
 “I feel miserable when I 
experience the side effects of 
treatment” (NO001) 
 
15 (33%) 
Anxiety “When I think about my 
situation I start to get this rush 
of thoughts, a lot of things 
come into my mind at the same 
time and I feel disorientated 
and a bit afraid” (PO005) 
 
7 (16%) 
Preoccupation with illness 
and heightened awareness 
of symptoms 
“I find it difficult to concentrate 
or think constructively because 
of thoughts of disease” (PO012) 
3 (7%) 
Embarrassment “…my face was swollen, I was 
too embarrassed to leave the 
house.” (IS003) 
 
1 (2%) 
Fear of recurrence “I worry about recurrence since 
the cancer already recurred four 
times” (NL008) 
5 (11%) 
Worry about what the 
future holds and life not 
returning to normal 
“Though the doctors say I 
should be alright once the 
treatment ends I feel afraid of 
what is going to happen in a 
year or more” (PO001)  
 
8 (18%) 
Worry about the long term 
effects of cancer and its 
treatment 
“I worry about the long-term 
effects of the disease and 
treatment” (PO004) 
1 (2%) 
Worry about dying “I know that I am being treated 
but I am very afraid of dying 
(PO011) 
1 (2%) 
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Shock of diagnosis “I did not expect that such a 
thing could happen to me” 
(PO011) 
 
4 (9%) 
Anger “…angry at being disfigured” 
(PO006) 
3 (7%) 
Feel let down by your body “…felt let down by my body, 
had no control” (NL004) 
2 (4%) 
Boredom “frequent visits and stays at 
hospital bore me” (PO008) 
 
4 (9%) 
Body image  16 (36%) 
Altered appearance  “when you look in the mirror, 
you don’t look like yourself, 
you look dead” (UK005) 
14 (31%) 
More self-conscious  “…what do they think about 
my disease, how do they look at 
me, how do girls look at me?” 
(IS003) 
 
4 (9%) 
Less concerned about 
appearance 
“I am less concerned about 
appearance and other’s 
opinions of me” (NL008) 
1 (2%) 
Self-appraisals  21 (47%) 
Lowered self-confidence / 
self-esteem 
“I lost confidence in myself and 
the world” (PO003) 
5 (11%) 
Greater self-awareness “I learned something about 
myself because of cancer” 
(NE003) 
1 (2%) 
Stronger person “I am mentally stronger” 
(PO005) 
4 (9%) 
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Better person “Cancer has made me a better 
and richer person and therefore 
I am thankful” (NL009) 
1 (2%) 
More positive person “…it impacts you as a person, I 
am now a more positive 
person” (UK001) 
3 (7%) 
Braver “I feel a lot more braver” 
(UK007) 
1 (2%) 
Increased maturity “Compared to my friends, I feel 
more grown up” (NO003) 
2 (4%) 
Greater confidence “I am proud cancer does not 
control my life which gives me 
the feeling I can do and handle 
everything by my own way of 
coping” (NL010) 
4 (9%) 
More sympathetic “It impacts you as a person, I 
am sympathetic to others, more 
sensitive to others, more 
motivated to help others” 
(UK001) 
1 (2%) 
Outlook on life  15 (33%) 
More positive outlook on 
life 
“I now have a more positive 
outlook on life and the future” 
(UK004) 
2 (4%) 
Different priorities in life “I’ve learnt how to prioritize 
the important things in life and 
understand what is important in 
life” (PO010) 
5 (11%) 
Greater desire to live life to 
the fullest 
“Life takes on an intensity, I 
realized the  importance of 
making each minute count…it 
gives you a pathway, and 
3 (7%) 
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motivation to do things” 
(UK005) 
Greater life experience “The disease brought me life 
experience, medical knowledge 
and different emotions” 
(NL012) 
1 (2%) 
Greater motivation to 
achieve personal goals 
“It gives you a pathway and 
motivation to achieve things” 
(UK005)“ 
2 (4%) 
Greater awareness of one’s 
mortality 
“I had to confront my own 
mortality” (UK005) 
2 (4%) 
Inability to plan for the 
future 
“I’ve stopped making plans for 
the future” (IS004) 
“I cannot think of the future” 
(FR001) 
2 (4%) 
Lifestyle  8 (18%) 
Motivation to lead a 
healthier lifestyle 
“I no longer participate in 
“risky” behaviours” (NO002) 
4 (9%) 
Take greater care to avoid 
infections 
“I have to be a lot more careful 
to avoid infections, something I 
took for granted when healthy” 
(UK001) 
5 (11%) 
Restricted diet (food and 
drink) 
“I miss takeaway food” 
(UK001) 
4 (9%) 
Treatment-related  14 (31%) 
Difficulty adjusting to 
being ill and having to take 
medication 
“…difficulty adjusting to a 
different path in life imposed 
by disease” (IS009) 
2 (4%) 
Dissatisfaction with care “Doctors didn’t take me 
seriously and would talk to my 
parents rather than me, I felt as 
if I wasn’t treated properly” 
(UK005) 
6 (13%) 
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Lack of age appropriate 
care 
“I had to ask my doctor about 
fertility preservation, no good 
information was given” 
(NL001) 
“…no information about age-
specific effects” (NL002) 
5 (11%) 
Treatment burden “Frequent visits and stays at 
hospital bore me” (PO008) 
2 (4%) 
Fertility  11 (24%) 
  “I worry that cancer might 
affect my ability to have 
children” (PO004) 
 
Financial  6 (13%) 
 “…I look forward to resuming 
these plans (travel) when I’m in 
remission but I am worried 
about expensive travel 
insurance” (UK005) 
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